Login to Your Account


Financings Roundup

Regentis Raises $10M for Knee Cartilage Regeneration Product

By Catherine Shaffer
Staff Writer

Tuesday, May 15, 2012
A Series C financing round of $10 million will support clinical studies and commercial launch of Regentis Biomaterials Ltd.'s knee cartilage regeneration product, GelrinC, in Europe, including a sales force and a postmarket study.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription


»

For Sales Inquiries,
http://clarivate.com/life-sciences/news/bioworld/#

 
Privacy Policy | Terms of Use | Copyright
 
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Clarivate Analytics